Literature DB >> 8594899

DNA synthesis and multinucleation in embryonic stem cell-derived cardiomyocytes.

M G Klug1, M H Soonpaa, L J Field.   

Abstract

The proliferative capacity of embryonic stem (ES) cell-derived cardiomyocytes was assessed. Enriched preparations of cardiomyocytes were isolated by microdissection of the cardiogenic regions of cultured embryoid bodies. The identity of the isolated cells was established by immunocytology, and mitotic activity was monitored by [3H]thymidine incorporation and pulse-chase experiments. ES-derived cardiomyocytes were mitotically active and predominantly mononucleated at 11 days after cardiogenic induction. By 21 days postinduction, cardiomyocyte DNA synthesis was markedly decreased, with a concomitant increase in the percentage of multinucleated cells. Interestingly, the duration of active cardiomyocyte reduplication in the ES system appeared to be roughly similar to that observed during normal murine cardiogenesis. Given these observations, as well as the genetic tractability of ES cells, ES-derived cardiogenesis might provide a useful in vitro system with which to assess the molecular regulation of the cardiomyocyte cell cycle.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8594899     DOI: 10.1152/ajpheart.1995.269.6.H1913

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  13 in total

1.  Targeted inactivation of alphai2 or alphai3 disrupts activation of the cardiac muscarinic K+ channel, IK+Ach, in intact cells.

Authors:  M O Sowell; C Ye; D A Ricupero; S Hansen; S J Quinn; P M Vassilev; R M Mortensen
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

2.  Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts.

Authors:  M G Klug; M H Soonpaa; G Y Koh; L J Field
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

3.  Proliferation of cardiomyocytes derived from human embryonic stem cells is mediated via the IGF/PI 3-kinase/Akt signaling pathway.

Authors:  Todd C McDevitt; Michael A Laflamme; Charles E Murry
Journal:  J Mol Cell Cardiol       Date:  2005-10-19       Impact factor: 5.000

Review 4.  Cardiac repair by embryonic stem-derived cells.

Authors:  M Rubart; L J Field
Journal:  Handb Exp Pharmacol       Date:  2006

5.  Formation of human myocardium in the rat heart from human embryonic stem cells.

Authors:  Michael A Laflamme; Joseph Gold; Chunhui Xu; Mohammad Hassanipour; Elen Rosler; Shailaja Police; Veronica Muskheli; Charles E Murry
Journal:  Am J Pathol       Date:  2005-09       Impact factor: 4.307

6.  The mouse as a model system to study cardiac regeneration.

Authors:  Marc Michael Zaruba; Loren J Field
Journal:  Drug Discov Today Dis Models       Date:  2008

7.  Derivation of pluripotent stem cells from cultured human primordial germ cells.

Authors:  M J Shamblott; J Axelman; S Wang; E M Bugg; J W Littlefield; P J Donovan; P D Blumenthal; G R Huggins; J D Gearhart
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

8.  Human embryonic germ cell derivatives express a broad range of developmentally distinct markers and proliferate extensively in vitro.

Authors:  M J Shamblott; J Axelman; J W Littlefield; P D Blumenthal; G R Huggins; Y Cui; L Cheng; J D Gearhart
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

9.  Enhanced proliferation of monolayer cultures of embryonic stem (ES) cell-derived cardiomyocytes following acute loss of retinoblastoma.

Authors:  Satoshi Yamanaka; Ihor Zahanich; Robert P Wersto; Kenneth R Boheler
Journal:  PLoS One       Date:  2008-12-10       Impact factor: 3.240

Review 10.  The immune boundaries for stem cell based therapies: problems and prospective solutions.

Authors:  Abdelkrim Hmadcha; Hmadcha Abdelkrim; Juan Domínguez-Bendala; Domínguez-Bendala Juan; Jane Wakeman; Wakeman Jane; Mohamed Arredouani; Arredouani Mohamed; Bernat Soria; Soria Bernat
Journal:  J Cell Mol Med       Date:  2009-07-06       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.